NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Diagnostics & Research · USD

Inotiv, Inc. (NOTV) Stock Analysis

Inotiv, Inc. (NOTV) is a Diagnostics & Research stock listed on NASDAQ and quoted in US Dollar.

NOTV

$0.01

$0.00 (0.00%)

Last trade July 27, 2026

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NOTV with… →

NOTV Key Statistics

As of Jul 27, 2026
Trading
Open
$0.01
Previous Close
$0.01
52-Week Range
0.22–3.32
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
3.83
Valuation
Market Cap
$9.42M
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−2.48
Financials (FY)
Revenue (FY)
$513.02M+4.54%
Net Income (FY)
−$68.63M
Profit marginThe share of revenue left as profit after all costs and taxes.
−17.14%
1-Year Return
−99.50%
Dividend and dates
Avg Volume
765.10K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

NOTV Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−98.02%
2025−86.73%

As of July 27, 2026.

NOTV Revenue and Earnings by Fiscal Year

FY ends September
Fiscal yearRevenueNet incomeNet margin
2025$513.02M−$68.63M−13.4%
2024$490.74M−$108.45M−22.1%
2023$572.43M−$105.14M−18.4%
2022$547.66M−$337.02M−61.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$513.02M$120.98M−$37.00M−$68.63M−13.4%
2024$490.74M$111.17M−$54.46M−$108.45M−22.1%
2023$572.43M$181.94M−$9.24M−$105.14M−18.4%
2022$547.66M$157.21M$20.25M−$337.02M−61.5%

Annual figures as reported, in the company's reporting currency. As of September 30, 2025.

NOTV Valuation vs Diagnostics & Research Median

Median of 49 stocks
MetricNOTVDiagnostics & Research medianvs median
P/S ratio0.024.990.0x the median
Profit margin−17.14%0.00%17.1 pts below

Medians across 49 Diagnostics & Research stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Inotiv, Inc. (NOTV) carries a market capitalisation of $9.42M. It is classified in the Diagnostics & Research industry, within the Healthcare sector. Headcount on file is 1,945.

Over the past 52 weeks the price has ranged from $0.22 to $3.32. NOTV last closed at $0.01 on July 27, 2026. The close was unchanged from the previous session.

Financial Health

Fiscal 2025 revenue came to $513.02M. That is +4.54% against the prior fiscal year, when revenue was $490.74M. The same year closed with a net loss of $68.63M. Profit margin runs at −17.14%. That is 17.1 percentage points below the Diagnostics & Research median of 0%. Earnings per share on a trailing basis come to −2.48.

Across the 4 fiscal years on file, revenue moves from $547.66M in 2022 to $513.02M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

Beta against the wider market is reported at 3.83. Annualized volatility over the trailing 1 year is 162.25%. Over the trailing twelve months the price has returned −99.50%. The stored price history starts on January 13, 2025, and the total return since then is −99.74%.

Growth & Income

The record shows no dividend for NOTV.

The record holds one complete calendar year, 2025, which returned −86.73%. So far in 2026 the price is −98.02%.

Peer Comparison

Inotiv, Inc. (NOTV) operates in the Diagnostics & Research industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Inotiv, Inc. NOTV $9.42M —
Thermo Fisher Scientific Inc. TMO $226.94B 33.0
Danaher Corporation DHR $145.98B 37.0
Natera, Inc. NTRA $47.31B —

The Diagnostics & Research industry average P/E ratio is 33.1x. Inotiv, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of July 27, 2026.

Related Diagnostics & Research Stocks

TMO

Thermo Fisher Scientific Inc.

$226.94B

 DHR

Danaher Corporation

$145.98B

 NTRA

Natera, Inc.

$47.31B

 IQV

IQVIA Holdings Inc.

$44.07B

 A

Agilent Technologies, Inc.

$42.54B

 IDXX

IDEXX Laboratories, Inc.

$42.18B
View all Diagnostics & Research stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Inotiv, Inc.

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Visit website →